Correlation Between Eli Lilly and Zura Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and Zura Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and Zura Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and Zura Bio Limited, you can compare the effects of market volatilities on Eli Lilly and Zura Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of Zura Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and Zura Bio.

Diversification Opportunities for Eli Lilly and Zura Bio

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Eli and Zura is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and Zura Bio Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zura Bio Limited and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with Zura Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zura Bio Limited has no effect on the direction of Eli Lilly i.e., Eli Lilly and Zura Bio go up and down completely randomly.

Pair Corralation between Eli Lilly and Zura Bio

Considering the 90-day investment horizon Eli Lilly and is expected to generate 0.5 times more return on investment than Zura Bio. However, Eli Lilly and is 2.02 times less risky than Zura Bio. It trades about 0.15 of its potential returns per unit of risk. Zura Bio Limited is currently generating about -0.35 per unit of risk. If you would invest  77,200  in Eli Lilly and on November 1, 2024 and sell it today you would earn a total of  5,123  from holding Eli Lilly and or generate 6.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Eli Lilly and  vs.  Zura Bio Limited

 Performance 
       Timeline  
Eli Lilly 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Eli Lilly and are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong essential indicators, Eli Lilly is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Zura Bio Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zura Bio Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Eli Lilly and Zura Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eli Lilly and Zura Bio

The main advantage of trading using opposite Eli Lilly and Zura Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, Zura Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zura Bio will offset losses from the drop in Zura Bio's long position.
The idea behind Eli Lilly and and Zura Bio Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities